Outcomes of adjuvant whole-brain radiotherapy versus hypofractionated stereotactic radiotherapy after surgical resection of brain metastases: a propensity score-matched analysis.

Fiche publication

Date publication

juin 2020

Journal

Chinese clinical oncology

Auteurs

Membres identifiés du Cancéropôle Est :
Pr ANTONI Delphine , Pr NOEL Georges

Tous les auteurs :
Keller A, Lefebvre F, Ricard D, Noël G, Antoni D

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/32576020

Résumé

To assess the risks of local and distant failure and overall survival time in patients treated with hypofractionated stereotactic radiotherapy (HFSRT) to the postoperative cavity for brain metastases (BMs) compared with patients treated with adjuvant whole-brain radiation therapy (WBRT).